[Olmesartan after experimental myocardial infarct compared with ramipril: organ protective effect].
Kintscher
Ulrich
U
Center for Cardiovascular Research, Institut für Pharmakologie und Toxikologie, Campus Charité Mitte, HessischeStrasse 3-4, 10115 Berlin.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004036:Diet, Atherogenic; D004353:Drug Evaluation, Preclinical; D007093:Imidazoles / Q000494:pharmacology*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000451:nursing; D017257:Ramipril / Q000494:pharmacology*; D051381:Rats; D013777:Tetrazoles / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan; D017257:Ramipril